Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine

We identified relapse/maintenance-of-response (MOR) predictors following discontinuation of long-term atomoxetine treatment in pediatric and adult patients with attention-deficit/hyperactivity disorder (ADHD) and assessed correlations between ADHD symptoms and quality of life (QoL). Post hoc analyse...

Full description

Saved in:
Bibliographic Details
Main Authors: Thome, Johannes (Author) , Dittmann, Ralf (Author)
Format: Article (Journal)
Language:English
Published: 5 May 2017
In: ADHD Attention Deficit and Hyperactivity Disorders
Year: 2017, Volume: 9, Issue: 4, Pages: 219-229
ISSN:1866-6647
DOI:10.1007/s12402-017-0227-8
Online Access:Verlag, Pay-per-use, Volltext: http://dx.doi.org/10.1007/s12402-017-0227-8
Verlag, Pay-per-use, Volltext: https://link.springer.com/article/10.1007/s12402-017-0227-8
Get full text
Author Notes:Johannes Thome, Ralf W. Dittmann, Laurence L. Greenhill, Sarah Lipsius, Yoko Tanaka, Chris Bushe, Rodrigo Escobar, Alexandra N. Heinloth, Himanshu Upadhyaya

MARC

LEADER 00000caa a2200000 c 4500
001 1572589612
003 DE-627
005 20220814131312.0
007 cr uuu---uuuuu
008 180503s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s12402-017-0227-8  |2 doi 
035 |a (DE-627)1572589612 
035 |a (DE-576)502589612 
035 |a (DE-599)BSZ502589612 
035 |a (OCoLC)1341008266 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 11  |2 sdnb 
100 1 |a Thome, Johannes  |e VerfasserIn  |0 (DE-588)1079452567  |0 (DE-627)841132399  |0 (DE-576)172532957  |4 aut 
245 1 0 |a Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine  |c Johannes Thome, Ralf W. Dittmann, Laurence L. Greenhill, Sarah Lipsius, Yoko Tanaka, Chris Bushe, Rodrigo Escobar, Alexandra N. Heinloth, Himanshu Upadhyaya 
264 1 |c 5 May 2017 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.05.2018 
520 |a We identified relapse/maintenance-of-response (MOR) predictors following discontinuation of long-term atomoxetine treatment in pediatric and adult patients with attention-deficit/hyperactivity disorder (ADHD) and assessed correlations between ADHD symptoms and quality of life (QoL). Post hoc analyses of data from two randomized, double-blind, placebo-controlled, phase 3 withdrawal studies in patients with ADHD meeting predefined response criteria before randomization. Study 1: patients (N = 163; 6-15 years) received atomoxetine (1.2-1.8 mg/kg/day) for 1 year, followed by randomization to atomoxetine (n = 81) or placebo (n = 82) for 6 months. Study 2: patients (N = 524; 18-50 years) received atomoxetine (80-100 mg/day) for ~6 months, followed by randomization to atomoxetine (n = 266) or placebo (n = 258) for ~6 months. Placebo patients were used for the analyses. Relapse: ≥50% worsening of prerandomization improvement in ADHD symptoms and ≥2 level severity increase on the Clinical Global Impression-Severity (CGI-S) scale at 2 consecutive visits; MOR: retaining ≥75% of prerandomization symptom improvement and CGI-S ≤ 2 at all visits (study 1); retaining ≥70% of prerandomization symptom improvement and CGI-S ≤ 3 at all visits (study 2). In adults, statistically significantly (P ≤ .05) increased likelihood of relapse was associated with prerandomization presence of Conners’ Adult Attention-Deficit/Hyperactivity Disorder Rating Scale-Investigator-Rated:Screening Version (CAARS-Inv:SV) items “difficulty awaiting turn” and “careless mistakes.” In pediatric patients, less MOR was associated with prerandomization presence of ADHD Rating Scale-IV-Parent Version Investigator-Rated item “does not listen”; in adults, less MOR was associated with prerandomization presence of CAARS-Inv:SV items “loses things” and “difficulty awaiting turn.” Changes in patients’ QoL after withdrawal from atomoxetine moderately correlated with changes in ADHD symptoms in pediatric patients and mildly in adults. 
700 1 |a Dittmann, Ralf  |e VerfasserIn  |0 (DE-588)1032941170  |0 (DE-627)739784323  |0 (DE-576)38041337X  |4 aut 
773 0 8 |i Enthalten in  |t ADHD Attention Deficit and Hyperactivity Disorders  |d Wien [u.a.] : Springer, 2009  |g 9(2017), 4, Seite 219-229  |h Online-Ressource  |w (DE-627)595709958  |w (DE-600)2486747-0  |w (DE-576)307016315  |x 1866-6647  |7 nnas  |a Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine 
773 1 8 |g volume:9  |g year:2017  |g number:4  |g pages:219-229  |g extent:11  |a Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine 
856 4 0 |u http://dx.doi.org/10.1007/s12402-017-0227-8  |x Verlag  |x Resolving-System  |z Pay-per-use  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s12402-017-0227-8  |x Verlag  |z Pay-per-use  |3 Volltext 
951 |a AR 
992 |a 20180503 
993 |a Article 
994 |a 2017 
998 |g 1032941170  |a Dittmann, Ralf  |m 1032941170:Dittmann, Ralf  |d 60000  |e 60000PD1032941170  |k 0/60000/  |p 2 
999 |a KXP-PPN1572589612  |e 3007840430 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 03.05.2018"],"physDesc":[{"extent":"11 S."}],"id":{"doi":["10.1007/s12402-017-0227-8"],"eki":["1572589612"]},"title":[{"title_sort":"Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine","title":"Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine"}],"language":["eng"],"origin":[{"dateIssuedDisp":"5 May 2017","dateIssuedKey":"2017"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Thome, Johannes","family":"Thome","given":"Johannes","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Dittmann","given":"Ralf","display":"Dittmann, Ralf"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"dateIssuedDisp":"2009-2019","publisher":"Springer","dateIssuedKey":"2009","publisherPlace":"Wien [u.a.]"}],"pubHistory":["1.2009 - 11.2019; damit Ersch. eingest."],"title":[{"title":"ADHD Attention Deficit and Hyperactivity Disorders","title_sort":"ADHD Attention Deficit and Hyperactivity Disorders"}],"disp":"Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetineADHD Attention Deficit and Hyperactivity Disorders","recId":"595709958","part":{"year":"2017","pages":"219-229","volume":"9","issue":"4","extent":"11","text":"9(2017), 4, Seite 219-229"},"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2486747-0"],"eki":["595709958"],"issn":["1866-6647"]}}],"name":{"displayForm":["Johannes Thome, Ralf W. Dittmann, Laurence L. Greenhill, Sarah Lipsius, Yoko Tanaka, Chris Bushe, Rodrigo Escobar, Alexandra N. Heinloth, Himanshu Upadhyaya"]},"recId":"1572589612"} 
SRT |a THOMEJOHANPREDICTORS5201